Please join us for an exclusive panel discussion on the future of the Life Science Hub Zug / Switzerland. This event will convene CEOs, senior executives, and key stakeholders to examine Switzerland’s strategic role in driving innovation in life sciences and to highlight Zug as a hotspot for global healthcare excellence. Our distinguished speakers will examine how Switzerland continues to drive breakthrough innovation and how Zug responds to the requirements. They will share their recommendations on how to keep the regional life science hub Zug relevant.

We invite you to participate in an engaging discussion between Dr. med. Katharina Gasser, General Manager, Roche Pharma Switzerland, Max Pahlow, Managing Director, Johnson & Johnson Innovative Medicine Switzerland, and Chantal Le Floch, VP, Head International Oncology Regulatory Strategy - Zug site Lead, Pfizer, moderated by Swiss-American Chamber of Commerce CEO Dr. Rahul Sahgal. The topic will be introduced by Roberto Busin, Chairman of the Board, Fusion Consulting, a boutique life-science consulting firm.

This discussion offers an opportunity for senior executives to gain exclusive insights into the strategic future of life sciences in Switzerland, to hear directly from leading voices shaping the sector worldwide, and to connect with peers who are defining the next chapter of global life science innovation.

Supported by Roche and Fusion Consulting